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Warfarin (4-OH coumarin) and its congeners are anticoagulants 
whose biological activity is based on vitamin K (vit. K) antago-
nism and subsequent inhibition of the vitamin K-dependent 
(VKD) step in the complete synthesis of a number of blood 
coagulation factors required for normal hemostasis (S h e a r e r , 
1990). Based on these activities, hydroxycoumarin anticoagu-
lants have found wide application as anticoagulant rodenticides 
(L u n d, 1988) and in prophylactic medicine to prevent throm-
boembolic disorders for more than 50 years (F u r i e , 2000). 
Warfarin (WF) and its analogs inhibit vit. K epoxide reductase 
(VKOR), leading to depletion of the hydroquinone form of vit. 
K, a cofactor for γ-glutamyl carboxylase which mediates post-
translational modification (carboxylation) of nascent glutamyl 
(Gla) residues needed for biological activity of coagulation 
factors (W a l l i n and H u t s o n, 2004). Prevention of normal 
production of these essential blood clotting factors by hydroxy-
coumarin anticoagulants leads to increase of clotting time up 
to the point where no clotting occurs. By inhibiting VKOR, 
however, WF affects the generation of biologically active VKD 
proteins required for biological processes other than hemo-
stasis, including proteins involved in the regulation of bone 
growth and calcification (bone Gla protein, BGP/osteocalcin 
and matrix Gla protein, MGP) (P r i c e, 1988) and proteins 
involved in mesangial and vascular smooth muscle cell growth 
and signaling (N a k a n o  et al., 1997; Y a n a g i t a  et al., 1999). 
Data which demonstrated WF effects on proteins not dependent 
on vit. K (non-VKD proteins), including molecules involved in 
signal transduction (K a t e r et al., 2002), and the discovery of             
VKD proteins with as yet unknown function (S h e a r e r, 2006) 
imply broader effects of hydroxycoumarin-type anticoagulant 
rodenticides on cell/tissue physiology. 
Intensive application of anticoagulant rodenticides as a 
means of controlling pest rodents has raised concern about pos-
sible exposure of both humans and non-target animals to these 
agents. In cases of incidents of WF intoxication, systemic effects 
(coagulopathies, occasionally with fatal outcome) were mainly 
described (W H O, 1995). Clinical studies revealed cases of 
adverse effects of WF therapy including embryopathy and loss 
of bone mass in patients on prolonged therapy (WHO, 1995) 
as well as various other side effects, including skin necrosis 
(H e r m e s  et al., 1997).  In 1995, the World Health Organization 
Environmental Health Criteria (EHC) Program categorized WF and 
other hydroxycoumarins as highly dangerous agents (W H O, 1995), 
highlighting the need for information about their biological effects. 
Along with traditional toxicity studies, immunotoxicity inves-
tigation is a recommended approach in examining the adverse 
effects of chemicals (WHO, 1996). Our previous study demon-
strated an immunotoxic capacity of WF in the form of suppres-
sion of cells of the lymphoid compartment in an experimental 
model of the contact hypersensitivity reaction in laboratory rats 
(K a t a r a n o v s k i  et al., 2003). To obtain initial information 
concerning the immunotoxicity of WF on innate immunity of 
cells, the effect of WF administration in vivo on granulocytes in 
rats was assessed. Quantitative changes (total and differential 
cell numbers) and the activation status of peripheral blood 
granulocytes and granulocytes migrating into subcutaneously 
implanted sponges containing WF were analyzed. The obtained 
data were obtained which suggest peripheral blood granulocyte 
activation following exposure to WF in vivo. 
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Fig.1. Peripheral blood granulocyte activity following WF appli-
cation (* p<0.05 vs control WF 0).
Warfarin-sodium, WF (Serva, FR Germany) dissolved in 
nonpyrogenic saline was applied intraperitoneally (i.p.) to male 
Albino Oxford (AO) rats in doses of 0.05 and 0.5 mg/kg body 
mass for one day (1x) and for three consecutive days (3x). WF 
bioactivity was assessed by measuring prothrombin (PT) time 
(in seconds) in the blood of treated rats, employing a one-stage 
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method with citrate blood plasma and thromborel S (K u r a t a 
and H o r i i, 2004). Total and differential blood leukocyte 
counts were performed on whole blood smears stained by the 
May-Grunwald-Giemsa method. Peripheral blood granulocytes 
were isolated 24 hours after the last application by dextran sedi-
mentation and density-gradient centrifugation as described pre-
viously (K a t a r a n o v s k i  et al., 2003). Activity of granulocites 
was evaluated by measuring their responsiveness to exogenous 
stimulation (granulocyte priming). A cytochemical assay for the 
respiratory burst of granulocytes (M o n b o i s s e  et al., 1991), 
based on their phorbol-12-myristate-13-acetate (PMA)-stimu-
lated ability to reduce nitroblue tetrazolium salt (NBT), was 
used. The direct effect of WF on granulocytes was examined 
using the subcutaneously-implanted sterile polyvinyl sponge 
model (P e j n o v i ć  et al., 1995) in a modification by which 
granulocytes migrate into sponges soaked in WF solution. One 
day after sponge implantation, migrating cells were isolated and 
their composition and activation status analyzed as described 
for peripheral blood granulocytes. Results are expressed as 
mean values ± standard deviation (SD) for each experimental 
group in ex vivo evaluation or as means ± standard errors 
(SE) for triplicates or quadruplicates from one representative 
experiment out of three in the case of in vitro measurements. 
Significance was defined by Student’s t-test, p  values  of less 
than 0.05 being considered significant.            
Intraperitoneal injection of the higher dose of WF resulted 
in increase of prothrombin (PT) time both after one application 
(122.3±10.9 s, p<0.001 vs control 27.66±9.26 s) and following 
three applications (126.5±6.3 s, p<0.001 vs control 26.7±4.3 s), 
demonstrating a basic biological effect of WF. One administra-
tion of 0.05 mg of WF/kg or 0.5 mg of WF/kg resulted in no 
changes in total and differential leukocyte numbers (Table 1). 
Administration of the lower dose of WF in a regime of three 
consecutive days resulted in increase in relative numbers of 
peripheral blood granulocytes and decrease in relative numbers 
of lymphocytes. Three-time application of the higher WF dose 
led to decrease in total leukocyte numbers. The massive internal 
hemorrhaging (with fatal outcome in 10% of the animals) noted 
at this regime of WF administration might account for the 
observed decrease. Administration of one lower or higher WF 
dose, as well as administration of the lower WF dose for three 
consecutive days resulted in an increase of granulocyte respon-
siveness to exogenous (PMA) stimulation. No changes were 
noted following application of the higher WF dose. The absence 
of a priming effect of WF might have resulted from its toxic-
ity in this regime of application, as quantitative data (decrease 
in total leukocyte numbers) suggest. Given the priming effect 
of WF administration on peripheral blood granulocytes, the 
direct effect of WF exposure on granulocytes was examined. 
No changes in numbers of cells migrating into WF-containing 
sponges or their priming status were noted (not shown). The 
absence of a direct effect of WF on sponge-granulocytes implies 
the need for metabolically processed WF for the observed gran-
ulocyte-priming activity and/or contribution of the systemic 
environment (peripheral blood) to activation of these cells. 
In conclusion, results presented in this paper demonstrated 
proinflammatory activity of warfarin administration. Along 
with our previous report regarding the immunosuppressive 
effects of warfarin, the presented results are a source of new data 
concerning the immunity-modulating potential of warfarin. 
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Table 1. Peripheral blood leukocyte numbers in rats following warfarin administration
 
Warfarin dose (mg/kg b.m.) 0 0.05 0.5
1x 3x 1x 3x 1x 3x
Total leukocytes (x109/L)a 6.03±1.23 5.57±0.79 8.35±2.85 5.90±1.58 4.67±0.093 3.20±1.07*
Neutrophils (%) 27.00±8.20 20.46±2.86 27.89±4.67 30.15±6.85 * 29.51±3.2 23.39±3.27
Lymphocytes (%) 72.10±7.60 79.50±2.50 71.92±4.76 68.99±6.50* 70.17±3.34 76.30±3.15
a Data represent means ± SD from 4-6 animals.  * p<0.05 vs control (WF 0).
